FAKTOR OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Boerse Frankfurt Warrants 15:50:26 2024-06-27 EDT | ||
| 11.09 EUR | +6.84% |
|
| Current month | +26.26% | ||
| 1 month | +19.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 11.06 | +6.55% |
| 24-06-26 | 10.38 | +2.37% |
| 24-06-25 | 10.14 | +1.00% |
| 24-06-24 | 10.04 | -0.79% |
| 24-06-21 | 10.12 | +4.12% |
Real-time Boerse Frankfurt Warrants
Last update June 27, 2024 at 03:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
BNP Paribas
|
| WKN | PE3EDW |
| ISIN | DE000PE3EDW0 |
| Date issued | 2022-03-11 |
| Strike | 91.56 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 50 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 90.69 € |
|---|---|
| Lowest since issue | 3.93 € |
| Spread | 0.1 € |
| Spread % | 0.90% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
93.34
USD
Average target price
96.05
USD
Spread / Average Target
+2.91%
- Stock Market
- Certificates
- Certificat
